Cas:1187385-80-3 Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate manufacturer & supplier

Chemical Name:Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate

CAS.NO:1187385-80-3

Synonyms:methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate

Molecular Formula:C₁₃H₁₃N₃O₃

Molecular Weight:259.26100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:88.06000

Exact Mass:259.09600

LogP:1.45110

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate Use and application,methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate technical grade,usp/ep/jp grade.

Related News: A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate manufacturer After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate supplier After this long manufacturing process, it is purified until it reaches a very high degree of purity and finally becomes an API. Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate vendor The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented. Methyl 2-amino-4-(3-methoxyphenyl)pyrimidine-5-carboxylate factory The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.